Penumbra, Inc Investment Income, Interest
Penumbra, Inc (PEN) reported Investment Income, Interest of $5.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-30
- Penumbra, Inc investment income, interest for the quarter ending 2026-06-30 was $5.92M, a 48.28% increase year-over-year.
- Penumbra, Inc investment income, interest for the quarter ending 2026-03-31 was $4.87M, a 43.90% increase year-over-year.
- Penumbra, Inc investment income, interest for the quarter ending 2025-12-31 was $4.56M, a 39.19% increase year-over-year.
- Penumbra, Inc investment income, interest for the quarter ending 2025-09-30 was $4.36M, a 25.83% increase year-over-year.
- Penumbra, Inc investment income, interest for fiscal 2025 was $16.29M, a 19.02% increase from fiscal 2024.
- Penumbra, Inc investment income, interest for fiscal 2024 was $13.69M, a 100.59% increase from fiscal 2023.
- Penumbra, Inc investment income, interest for fiscal 2023 was $6.83M, a 261.88% increase from fiscal 2022.
- Penumbra, Inc investment income, interest for fiscal 2022 was $1.89M, a 34.31% decline from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.92M 10-Q · filed 2026-07-30 | $10.79M 10-Q · filed 2026-07-30 | $15.35M derived: sum of 3 quarters · filed 2026-07-30 | $19.71M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $4.87M 10-Q · filed 2026-05-06 | $9.43M derived: sum of 2 quarters · filed 2026-05-06 | $13.79M derived: sum of 3 quarters · filed 2026-05-06 | $17.78M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.92M derived: sum of 2 quarters · filed 2026-02-25 | $12.91M derived: sum of 3 quarters · filed 2026-07-30 | $16.29M 10-K · filed 2026-02-25 |
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-05 | $8.35M derived: sum of 2 quarters · filed 2026-07-30 | $11.73M 10-Q · filed 2025-11-05 | $15.01M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $3.99M 10-Q · filed 2026-07-30 | $7.37M 10-Q · filed 2026-07-30 | $10.65M derived: sum of 3 quarters · filed 2026-07-30 | $14.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $3.38M 10-Q · filed 2026-05-06 | $6.66M derived: sum of 2 quarters · filed 2026-05-06 | $10.13M derived: sum of 3 quarters · filed 2026-05-06 | $13.78M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.74M derived: sum of 2 quarters · filed 2026-02-25 | $10.40M derived: sum of 3 quarters · filed 2026-02-25 | $13.69M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.46M 10-Q · filed 2025-11-05 | $7.12M derived: sum of 2 quarters · filed 2025-11-05 | $10.41M 10-Q · filed 2025-11-05 | $13.42M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $3.66M 10-Q · filed 2025-07-29 | $6.95M 10-Q · filed 2025-07-29 | $9.96M derived: sum of 3 quarters · filed 2026-02-25 | $11.52M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $3.29M 10-Q · filed 2025-04-23 | $6.30M derived: sum of 2 quarters · filed 2026-02-25 | $7.86M derived: sum of 3 quarters · filed 2026-02-25 | $9.15M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.57M derived: sum of 2 quarters · filed 2026-02-25 | $5.85M derived: sum of 3 quarters · filed 2026-02-25 | $6.83M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.56M 10-Q · filed 2024-10-30 | $2.85M derived: sum of 2 quarters · filed 2024-10-30 | $3.82M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $1.28M 10-Q · filed 2024-07-30 | $2.25M 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $970.00K 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $1.89M 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $2.87M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |